Assessment of antithrombotic drugs ex vivo and in vivo.
D000818:Animals; D001241:Aspirin / Q000494:pharmacology; D002951:Citrates / Q000494:pharmacology; D003094:Collagen / Q000494:pharmacology; D004176:Dipyridamole / Q000494:pharmacology; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D006493:Heparin / Q000494:pharmacology; D010974:Platelet Aggregation / Q000187:drug effects*; D011817:Rabbits; D013442:Sulfinpyrazone / Q000494:pharmacology
D002951:Citrates; D005343:Fibrinolytic Agents; D004176:Dipyridamole; D006493:Heparin; D003094:Collagen; D001241:Aspirin; D013442:Sulfinpyrazone